Abstract CT212: Phase Ib/II, Global, Open-Label, Randomized Evaluation of Atezolizumab (atezo) + Etrumadenant (etruma) + Chemotherapy (chemo) Vs Chemo Alone in MORPHEUS-PDAC
CANCER RESEARCH(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CANCER RESEARCH(2024)